RE: A gross undervaluation...18 Mar 2019 10:20
great post. You have a drug with lilkely little side effects being used in breast cancer, MS and sub-arachnoid haemorrhage. No idea what the combined market of those is. £10's of billions probably.
looking forward to a significant re-rate here. I think before news this will be over 30p. massive potential